These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19352613)

  • 1. Beyond the Knudson's hypothesis in von Hippel-Lindau (VHL) disease-proposing vitronectin as a "gene modifier".
    Turturro F
    J Mol Med (Berl); 2009 Jun; 87(6):591-3. PubMed ID: 19352613
    [No Abstract]   [Full Text] [Related]  

  • 2. A vitronectin M381T polymorphism increases risk of hemangioblastoma in patients with VHL gene defect.
    Huang JS; Lin CM; Cheng YC; Hung KL; Chien CC; Chen SK; Chang CJ; Chen CW; Huang CJ
    J Mol Med (Berl); 2009 Jun; 87(6):613-22. PubMed ID: 19288063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The von Hippel-Lindau tumor suppressor gene.
    Kondo K; Kaelin WG
    Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel gene mutation in von Hippel-Lindau disease - a report of two cases.
    Wang J; Cao W; Wang Z; Zhu H
    BMC Med Genet; 2019 Dec; 20(1):194. PubMed ID: 31823746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
    Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
    Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Hippel-Lindau syndrome: molecular mechanisms of the disease.
    Calzada MJ
    Clin Transl Oncol; 2010 Mar; 12(3):160-5. PubMed ID: 20231120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal exclusion of von Hippel-Lindau syndrome in a Mexican family carrying a novel VHL gene mutation].
    Chacón-Camacho OF; Benitez-Granados J; Zenteno JC
    Ginecol Obstet Mex; 2013 Apr; 81(4):206-10. PubMed ID: 23720934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects.
    Shehata BM; Stockwell CA; Castellano-Sanchez AA; Setzer S; Schmotzer CL; Robinson H
    Adv Anat Pathol; 2008 May; 15(3):165-71. PubMed ID: 18434768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell chondrosarcoma in Von Hippel-Lindau disease.
    Dreijerink KMA; van Leeuwaarde RS; Hackeng WM; Giles RH; de Leng WWJ; Jutte PC; Suurmeijer AJH; van Nesselrooij BPM; Brosens LAA
    Fam Cancer; 2020 Jan; 19(1):41-45. PubMed ID: 31673890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene symbol: VHL. Disease: von Hippel-Lindau syndrome. Accession #Hd0512.
    Mavrogiannis LA; Sheridan EG; Burnell LD; Taylor GR
    Hum Genet; 2006 Feb; 118(6):774-5. PubMed ID: 17297680
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
    Tedesco L; Elguero B; Pacin DG; Senin S; Pollak C; Garcia Marchiñena PA; Jurado AM; Isola M; Labanca MJ; Palazzo M; Yankilevich P; Fuertes M; Arzt E
    Cell Death Dis; 2019 Mar; 10(4):266. PubMed ID: 30890701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation analysis for a family affected with von Hippel-Lindau syndrome].
    Liu J; Wang Y; Wang S; Si H; Duan W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):860-863. PubMed ID: 30512164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
    Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human induced pluripotent stem cell (iPSC) lines from three patients with von Hippel-Lindau syndrome carrying distinct VHL gene mutations.
    Schuster J; Fatima A; Schwarz F; Klar J; Laan L; Dahl N
    Stem Cell Res; 2019 Jul; 38():101474. PubMed ID: 31176917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndrome.
    Santarpia L; Lapa D; Benvenga S
    Ann N Y Acad Sci; 2006 Aug; 1073():198-202. PubMed ID: 17102087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel human pathological mutations. Gene symbol: VHL. Disease: Von Hippel-Lindau syndrome.
    Castellano M
    Hum Genet; 2009 Aug; 126(2):340. PubMed ID: 19694021
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel human pathological mutations. Gene symbol: VHL. Disease: Von Hippel-Lindau syndrome.
    Ellison J
    Hum Genet; 2010 Apr; 127(4):477. PubMed ID: 21488287
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical utility gene card for: von Hippel-Lindau (VHL).
    Decker J; Neuhaus C; Macdonald F; Brauch H; Maher ER
    Eur J Hum Genet; 2014 Apr; 22(4):. PubMed ID: 23982691
    [No Abstract]   [Full Text] [Related]  

  • 20. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
    Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
    J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.